Latest Breaking News On - Mikhail kosiborod - Page 8 : comparemela.com

Weight-loss drug Wegovy has largest benefit ever seen for patients with heart failure, clinical trial finds

Weight-loss drug Wegovy has largest benefit ever seen for patients with heart failure, clinical trial finds
thenews-chronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenews-chronicle.com Daily Mail and Mail on Sunday newspapers.

United statesMikhail kosiborodSaint luke mid america heart instituteNovo nordiskNew england journalSaint lukeMid america heart instituteKansas cityKansas city cardiomyopathy questionnaire

SGLT2 inhibitors not linked with improved survival in hospitalized COVID-19 patients

SGLT2 inhibitors not linked with improved survival in hospitalized COVID-19 patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United kingdomRepublic ofSouth africaMikhail kosiborodWorld health organizationSaint luke mid america heart instituteHot lineRapid evidence appraisalWorking groupSaint lukeMid america heart instituteKansas city

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Sodium glucose co-transporter-2 (SGLT2) inhibitors do not lead to lower 28-day all-cause mortality compared with usual care or placebo in patients hospitalized with COVID-19, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

United kingdomRepublic ofSouth africaMikhail kosiborodLily ramseyWorld health organizationSaint luke mid america heart instituteHot lineRapid evidence appraisalWorking groupPresenting authorSaint lukeMid america heart instituteKansas cityCovid 19Heart failure

Semaglutide Offers Promising Weight Loss for Heart Failure Patients With Obesity

After one year, the drug Wegovy was shown to significantly improve mobility and reduce weight for people with heart failure and obesity.

United statesMikhail kosiborodJoseph wuAmerican heart associationSaint luke mid america heart instituteTulane university medical centerAmerican heartNew england journalSaint lukeMid america heart instituteKansas cityCould walk moreHad fewer physical limitations afterKansas city cardiomyopathy questionnaireShauna levyFlower weight

Meta-analysis shows SGLT2 inhibitors not beneficial in treating COVID-19

Meta-analysis shows SGLT2 inhibitors not beneficial in treating COVID-19
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Noord hollandEli lillyGreggc fonarowAlnylam pharmaBoehringer ingelheim eli lillyErik swainMikhail kosiborodByregina schafferSaint luke mid america heart instituteEuropean society of cardiology congressNovo nordiskUniversity of missouriBoehringer ingelheimKansas city school of medicineArtera healthEuropean society